N/A
Completed N=3,587
Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation
Source: ClinicalTrials.gov NCT02907944 ↗Enrolled (actual)
3,587
Serious AEs
—
Results posted
May 2023
Primary outcomePrimary: Change in Provision of Addiction Treatments — 66; 20; 268; 33 Participants — p=0.55
Summary
Tobacco, alcohol and opioid use disorders threaten the health of HIV-infected patients. What if evidence-based counseling and medication treatments for tobacco, alcohol and opioid use disorders (herein refered to as addiction treatments) were routinely provided in HIV clinics? Implementation Facilitation is an established strategy to increase the uptake of evidence-based treatments. Our goal is to evaluate the impact of Implementation Facilitation on the use of addiction treatments in four large HIV clinics.
The purpose of the WHAT-IF study is:
Aim 1. Among key stakeholders, to use quantitative and qualitative (mixed) methods to identify the site-specific evidence, context and facilitation-related barriers and facilitators to the integration of addiction treatments to help tailor an Implementation Facilitation for each clinic.
Aim 2. To evaluate the impact of Implementation Facilitation on:
2a: Organizational readiness to deliver addiction treatments 2b: Provider readiness to deliver addiction treatments 2c: Provision of addiction treatments 2d: Changes in organizational models of care used to deliver addiction treatments
Aim 3. To evaluate the impact of Implementation Facilitation on antiretroviral therapy receipt, HIV viral suppression, VACS Index, and retention in HIV care among patients eligible for addiction treatment.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Provision of Addiction Treatments |
66; 20; 268; 38; 15; 190 | 0.59 |
| SECONDARY Antiretroviral Therapy (ART) Receipt |
4106; 3508 | — |
| SECONDARY Viral Suppression |
3849; 2830 | — |
| SECONDARY VACS Index |
23.53; 25.12 | — |
| SECONDARY Retention in HIV Care |
3450 | — |
| SECONDARY Organizational Readiness |
4.37; 4.05; 4.13 | — |
| SECONDARY Provider Readiness |
6.75; 6.22; 7.24 | — |
| SECONDARY Provider Readiness: |
7.28; 7.16; 7.50 | — |
Eligibility Criteria
Inclusion Criteria
Patient inclusion criteria:
- HIV-infected
- Receiving HIV care in the index clinic
- Age >18 years old
- Meets criteria for lifetime or current tobacco, alcohol and/or opioid use disorder regardless of addiction treatment status
- Able to provide verbal informed consent
Staff inclusion criteria:
- Employed at participating HIV clinic for at least 6 months
- Able to provide verbal informed consent.
Payer/health insurance provider inclusion criteria:
- Employed at an organization or agency that provides funding for medical services for HIV-infected individuals for at least 6 months.
- Able to provide verbal informed consent.
Exclusion Criteria
- Unable to provide verbal informed consent
Data sourced from ClinicalTrials.gov (NCT02907944). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.